RNA interference directed to CDK2 inhibits HIV-1 transcription

Virology. 2005 Oct 25;341(2):171-8. doi: 10.1016/j.virol.2005.06.041. Epub 2005 Aug 8.

Abstract

We previously reported that cell cycle-dependent kinase 2 (CDK2) is required for human immunodeficiency virus-1 (HIV-1) Tat-dependent transcription in vitro. In the present study, CDK2-specific RNA interference in cultured HEK293T cells inhibited CDK2 expression and Tat-induced HIV-1 transcription from non-integrated HIV-1 promoter but not basal HIV-1 transcription or transcription from CMV or beta-actin promoters. Also, CDK2-specific RNA interference inhibited Tat-induced transcription from the integrated HIV-1 promoter in HeLa-CD4-LTR-beta-gal cells and potently blocked TNFalpha-induced HIV-1 viral replication in OM10.1 cells. CDK2-specific RNA interference did not have an effect on cell cycle progression, but it augmented TNFalpha-induced apoptosis of OM10.1 cells. Our results indicate that CDK2 participates in Tat-mediated HIV-1 transcription and may serve as a potential therapeutic target.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / genetics
  • Apoptosis
  • Cyclin-Dependent Kinase 2 / genetics*
  • Cyclin-Dependent Kinase 2 / physiology*
  • Cytomegalovirus / genetics
  • Gene Products, tat / metabolism*
  • HIV-1 / genetics*
  • Humans
  • Promoter Regions, Genetic
  • RNA Interference*
  • RNA, Small Interfering
  • Transcription, Genetic*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Virus Replication
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Actins
  • Gene Products, tat
  • RNA, Small Interfering
  • Tumor Necrosis Factor-alpha
  • tat Gene Products, Human Immunodeficiency Virus
  • CDK2 protein, human
  • Cyclin-Dependent Kinase 2